Daewoong Total Liabilities
Daewoong total liabilities. Based on the latest financial reports, Daewoong (003090) has total liabilities worth ₩1.60 Trillion KRW (≈ $1.08 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Daewoong (003090) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Daewoong (2000–2025)
Total liabilities of Daewoong from 2000 to 2025. This chart illustrates how Daewoong's total liabilities have evolved over time, based on quarterly financial data. Explore Daewoong strategic investment ratio to see how much of total assets are deployed in long-term investments.
Daewoong Competitors by Total Liabilities
The table below lists competitors of Daewoong ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Three Stars NM
SHG:603578
|
China | CN¥3.75 Billion |
|
Aarti Drugs Limited
NSE:AARTIDRUGS
|
India | Rs12.66 Billion |
|
BlackRock Energy and Resources Closed Fund
NYSE:BGR
|
USA | $1.72 Million |
|
Sampoerna Agro Tbk
JK:SGRO
|
Indonesia | Rp3.54 Trillion |
|
Beijing Tianyishangjia New Material Corp Ltd
SHG:688033
|
China | CN¥2.41 Billion |
|
Shanghai Canature Environmental
SHE:300272
|
China | CN¥2.16 Billion |
|
Northern Arc Capital Ltd
NSE:NORTHARC
|
India | Rs131.17 Billion |
|
MRV Engenharia e Participações S.A
SA:MRVE3
|
Brazil | R$22.36 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Daewoong's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Daewoong (003090) total assets.
Liquidity & Leverage Metrics
Daewoong Total Liabilities Ratios Explained
Daewoong total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Daewoong's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Daewoong (2000–2025)
The table below shows the annual total liabilities of Daewoong from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩1.46 Trillion ≈ $992.70 Million |
+20.25% |
| 2024-12-31 | ₩1.22 Trillion ≈ $825.56 Million |
+32.06% |
| 2023-12-31 | ₩922.48 Billion ≈ $625.15 Million |
+4.90% |
| 2022-12-31 | ₩879.41 Billion ≈ $595.96 Million |
+13.23% |
| 2021-12-31 | ₩776.67 Billion ≈ $526.34 Million |
+7.78% |
| 2020-12-31 | ₩720.61 Billion ≈ $488.35 Million |
+12.26% |
| 2019-12-31 | ₩641.93 Billion ≈ $435.02 Million |
+2.24% |
| 2018-12-31 | ₩627.86 Billion ≈ $425.49 Million |
+2.95% |
| 2017-12-31 | ₩609.85 Billion ≈ $413.28 Million |
+1.19% |
| 2016-12-31 | ₩602.65 Billion ≈ $408.41 Million |
+45.63% |
| 2015-12-31 | ₩413.82 Billion ≈ $280.44 Million |
+37.03% |
| 2014-12-31 | ₩302.00 Billion ≈ $204.66 Million |
+42.86% |
| 2013-12-31 | ₩211.40 Billion ≈ $143.26 Million |
+79.42% |
| 2012-12-31 | ₩117.83 Billion ≈ $79.85 Million |
-16.35% |
| 2011-12-31 | ₩140.85 Billion ≈ $95.45 Million |
-50.65% |
| 2010-12-31 | ₩285.42 Billion ≈ $193.43 Million |
+3.02% |
| 2009-12-31 | ₩277.06 Billion ≈ $187.76 Million |
+2.14% |
| 2008-12-31 | ₩271.26 Billion ≈ $183.83 Million |
+53.71% |
| 2007-12-31 | ₩176.48 Billion ≈ $119.60 Million |
+11.49% |
| 2006-12-31 | ₩158.29 Billion ≈ $107.27 Million |
+16.46% |
| 2005-12-31 | ₩135.92 Billion ≈ $92.11 Million |
+16.63% |
| 2004-12-31 | ₩116.54 Billion ≈ $78.98 Million |
+11.64% |
| 2003-12-31 | ₩104.39 Billion ≈ $70.74 Million |
-7.38% |
| 2002-12-31 | ₩112.71 Billion ≈ $76.38 Million |
-1.67% |
| 2001-12-31 | ₩114.63 Billion ≈ $77.68 Million |
-20.15% |
| 2000-12-31 | ₩143.55 Billion ≈ $97.28 Million |
-- |
About Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more